标题
Neisseria Adhesin A Variation and Revised Nomenclature Scheme
作者
关键词
-
出版物
Clinical and Vaccine Immunology
Volume 21, Issue 7, Pages 966-971
出版商
American Society for Microbiology
发表日期
2014-05-08
DOI
10.1128/cvi.00825-13
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase Variation of PorA, a Major Outer Membrane Protein, Mediates Escape of Bactericidal Antibodies by Neisseria meningitidis
- (2013) Isfahan Tauseef et al. INFECTION AND IMMUNITY
- MtrR Control of a Transcriptional Regulatory Pathway in Neisseria meningitidis That Influences Expression of a Gene (nadA) Encoding a Vaccine Candidate
- (2013) Jason M. Cloward et al. PLoS One
- An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands
- (2013) Stefania Bambini et al. PLoS One
- Conservation of Meningococcal Antigens in the Genus Neisseria
- (2013) A. Muzzi et al. mBio
- Transcriptional Regulation of thenadAGene in Neisseria meningitidis Impacts the Prediction of Coverage of a Multicomponent Meningococcal Serogroup B Vaccine
- (2012) Luca Fagnocchi et al. INFECTION AND IMMUNITY
- BIGSdb: Scalable analysis of bacterial genome variation at the population level
- (2011) Keith A Jolley et al. BMC BIOINFORMATICS
- Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)-mediated adhesion and invasion
- (2011) Paolo Montanari et al. CELLULAR MICROBIOLOGY
- In the NadR Regulon, Adhesins and Diverse Meningococcal Functions Are Regulated in Response to Signals in Human Saliva
- (2011) L. Fagnocchi et al. JOURNAL OF BACTERIOLOGY
- The Soluble Recombinant Neisseria meningitidis Adhesin NadAΔ351–405 Stimulates Human Monocytes by Binding to Extracellular Hsp90
- (2011) Paola Cecchini et al. PLoS One
- Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
- (2010) J. Lucidarme et al. Clinical and Vaccine Immunology
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Jalview Version 2--a multiple sequence alignment editor and analysis workbench
- (2009) A. M. Waterhouse et al. BIOINFORMATICS
- Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales
- (2009) J. Lucidarme et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA- OMVs, without further stimulating their proinflammatory activity on circulating monocytes
- (2009) Regina Tavano et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
- (2009) Stefania Bambini et al. VACCINE
- Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
- (2009) Susanne Jacobsson et al. VACCINE
- A Novel Phase Variation Mechanism in the Meningococcus Driven by a Ligand-Responsive Repressor and Differential Spacing of Distal Promoter Elements
- (2009) Matteo M. E. Metruccio et al. PLoS Pathogens
- B:2a:P1.5 Meningococcal Strains Likely Arisen from Capsular Switching Event Still Spreading in Spain
- (2008) J. Castilla et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Human monocytes/macrophages are a target of Neisseria meningitidis Adhesin A (NadA)
- (2008) Susanna Franzoso et al. JOURNAL OF LEUKOCYTE BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started